These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36568503)
21. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale. Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715 [TBL] [Abstract][Full Text] [Related]
22. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders. Wanning S; Süverkrüp R; Lamprecht A Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097 [TBL] [Abstract][Full Text] [Related]
23. The Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for Production. Kanojia G; Have RT; Bakker A; Wagner K; Frijlink HW; Kersten GF; Amorij JP PLoS One; 2016; 11(10):e0163109. PubMed ID: 27706175 [TBL] [Abstract][Full Text] [Related]
24. Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder. Brunaugh AD; Ding L; Wu T; Schneider M; Khalaf R; Smyth HDC J Pharm Sci; 2022 Feb; 111(2):403-416. PubMed ID: 34453927 [TBL] [Abstract][Full Text] [Related]
25. Manufacturing Solid Dosage Forms from Bulk Liquids Using the Fluid-bed Drying Technology. Qi J; Lu YI; Wu W Curr Pharm Des; 2015; 21(19):2668-76. PubMed ID: 25876914 [TBL] [Abstract][Full Text] [Related]
26. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy. Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996 [TBL] [Abstract][Full Text] [Related]
27. Comparing freeze drying and spray drying of interleukins using model protein CXCL8 and its variants. Fiedler D; Hartl S; Gerlza T; Trojacher C; Kungl A; Khinast J; Roblegg E Eur J Pharm Biopharm; 2021 Nov; 168():152-165. PubMed ID: 34474111 [TBL] [Abstract][Full Text] [Related]
28. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state. Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in freeze-drying: variables, cycle optimization, and innovative techniques. Mehanna MM; Abla KK Pharm Dev Technol; 2022 Oct; 27(8):904-923. PubMed ID: 36174214 [TBL] [Abstract][Full Text] [Related]
30. Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins. Marschall C; Witt M; Hauptmeier B; Friess W Eur J Pharm Biopharm; 2021 Apr; 161():37-49. PubMed ID: 33548460 [TBL] [Abstract][Full Text] [Related]
31. Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches. Ziaee A; Albadarin AB; Padrela L; Femmer T; O'Reilly E; Walker G Eur J Pharm Sci; 2019 Jan; 127():300-318. PubMed ID: 30428336 [TBL] [Abstract][Full Text] [Related]
32. Effects of drying method and excipient on structure and stability of protein solids using solid-state hydrogen/deuterium exchange mass spectrometry (ssHDX-MS). Wilson NE; Topp EM; Zhou QT Int J Pharm; 2019 Aug; 567():118470. PubMed ID: 31252148 [TBL] [Abstract][Full Text] [Related]
33. Inhalable microparticle platform based on a novel shell-forming lipid excipient and its feasibility for respirable delivery of biologics. Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Vehring R Eur J Pharm Biopharm; 2022 Aug; 177():308-322. PubMed ID: 35905804 [TBL] [Abstract][Full Text] [Related]
34. The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process. Poursina N; Vatanara A; Rouini MR; Gilani K; Najafabadi AR Acta Pharm; 2016 Jun; 66(2):207-18. PubMed ID: 27279064 [TBL] [Abstract][Full Text] [Related]
36. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles. Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908 [TBL] [Abstract][Full Text] [Related]
37. Application of freeze-drying in the development of oral drug delivery systems. Siow CR; Wan Sia Heng P; Chan LW Expert Opin Drug Deliv; 2016 Nov; 13(11):1595-1608. PubMed ID: 27267745 [TBL] [Abstract][Full Text] [Related]
38. Spray granulation for drug formulation. Loh ZH; Er DZ; Chan LW; Liew CV; Heng PW Expert Opin Drug Deliv; 2011 Dec; 8(12):1645-61. PubMed ID: 22097906 [TBL] [Abstract][Full Text] [Related]
39. Effect of Process Parameters, Protectants and Carrier Materials on the Survival of Yeast Cells during Fluidized Bed Granulation for Tableting. Vorländer K; Bahlmann L; Kwade A; Finke JH; Kampen I Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986745 [TBL] [Abstract][Full Text] [Related]
40. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review. Stärtzel P J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]